Molecular Oncology
Volume 2, Issue 1 , Pages 10-11, June 2008

The Stockholm Declaration☆

Cancer Center Karolinska, Department of Oncology, Karolinska University Hospital Solna, S-171 76 Stockholm, Sweden

published online 23 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This declaration is a public statement of commitment to the strategy and practice of a platform of comprehensive cancer centers (CCCs) and basic/preclinical cancer research centers. This initiative was launched on November 6th, 2007 in Stockholm, Sweden with 17 inaugural signatories.Alliance Against Cancer, Italy (Angelo Paradiso).Cancer Research UK Cambridge Research Institute, Cambridge, UK (Bruce Ponder, Carlos Caldas).Christie Hospital Manchester/Manchester Cancer Research Center, Manchester, UK (Chris Harrison).Danish Cancer Society, Institute of Cancer Biology, Copenhagen, Denmark (Julio E. Celis).Erasmus University Medical Center, Rotterdam, The Netherlands (Alexander Eggermont).European Institute of Oncology, Milan, Italy (Gordon McVie).German Cancer Research Center (DKFZ), Heidelberg, Germany (Otmar D. Wiestler).Institut Gustave-Roussy, Villejuif, France (Thomas Tursz).Institut Jules Bordet, Brussels, Belgium (Dominique de Valeriola).Institute Curie, Paris, France (Sergio Roman-Roman).Karolinska Institutet, Stockholm, Sweden (Ulrik Ringborg).The Netherlands Cancer Institute, Amsterdam, The Netherlands (Anton Berns).Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain (Mariano Barbacid).The Norwegian Radium Hospital Comprehensive Cancer Centre, Oslo, Norway (Anne-Lise Börresen-Dale).University of Oxford, Oxford, UK (David Kerr).Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (Marco Pierotti).

PII: S1574-7891(08)00037-9

doi:10.1016/j.molonc.2008.03.004

Molecular Oncology
Volume 2, Issue 1 , Pages 10-11, June 2008

Article Tools